157 results on '"Santinelli, Letizia"'
Search Results
2. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
3. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
4. The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy).
5. Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies
6. Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity
7. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
8. Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients
9. Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort
10. Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
11. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients
12. Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
13. Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
14. Differential expression of type I interferon and inflammatory genes in SARS-CoV-2 infected patients treated with monoclonal antibodies
15. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women
16. The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV
17. High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
18. Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
19. Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
20. Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients
21. Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
22. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
23. The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review
24. Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
25. Covid‐19 sequelae in working age patients: A systematic review
26. Antiretroviral Therapy Dampens Mucosal CD4+ T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
27. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
28. Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
29. Viral community acquired pneumonia at the emergency department: Report from the pre COVID‐19 age
30. Preliminary attempt to predict risk of invasive pulmonary aspergillosis in patients with influenza: Decision trees may help?
31. Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
32. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
33. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection
34. Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients
35. Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial
36. Covid‐19 sequelae in working age patients: A systematic review.
37. Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
38. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection
39. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
40. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
41. Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort
42. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
43. Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation
44. Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
45. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients
46. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS
47. Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
48. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
49. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
50. Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.